tm logo
Live/Registered
REGISTERED

on 30 Apr 2024

Last Applicant/ Owned by

12860 anielson Court, Suite B

Poway

US

92064

Serial Number

97251461 filed on 03rd Feb 2022

Registration Number

7375159 registered on 30th Apr 2024

in the Principal Register

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

Logo Mark Trademark Information

Research and development in the fields of gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; proceRead More

Classification Information


Class [045]
Personal & Legal & Social Services


Providing regulatory compliance and regulatory compliance consultation and advisory services with respect to relevant state and federal law for organizations in the pharmaceutical, biotech, life science, and other government-regulated industries


First Use Date in General

14th Feb 2022

First Use Date in Commerce

14th Feb 2022

Class [042]
Computer & Software Services & Scientific Services


Research and development in the fields of gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development in the fields of gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, research and development in the fields of assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services, namely, research and development in the fields of assaying, and purifying mitochondria, cell lysates, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in mammalians; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals; CMO (Contract evelopment and Manufacturing Organization) services, namely, pharmaceutical drug development services; material testing; product quality testing; scientific laboratory services; scientific research


First Use Date in General

14th Feb 2022

First Use Date in Commerce

14th Feb 2022

Class [040]
Treatment & Processing of Materials Services


Manufacturing services for others in the fields of gene therapy, modified gene therapy, modified cell therapy, cell therapy, tissue engineering and biopharmaceuticals, namely, custom manufacture of pharmaceuticals, chemotherapy drugs and antibiotic medicines by pharmaceutical compounders; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in mammalians, namely, custom manufacture of pharmaceuticals, chemotherapy drugs and antibiotic medicines by pharmaceutical compounders; manufacturing process consulting; Production in the nature of custom manufacture of cell lines for others using lentivirus technology; Production in the nature of custom manufacture of a recombinant or manipulated lentivirus; Production in the nature of custom manufacture of mitochondria, cell lysates, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in mammalians


First Use Date in General

14th Feb 2022

First Use Date in Commerce

14th Feb 2022

Mark Details


Serial Number

No 97251461

Mark Type

No Service Mark

Attorney Docket Number

No 260547.1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.13.03 -

Incomplete quadrilaterals and quadrilaterals made of broken or dotted lines

26.13.25 -

Quadrilaterals with one or more curved sides

26.13.28 -

Miscellaneous designs with overall quadrilateral shape

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.04 -

Vertical line(s), band(s) or bar(s)

26.17.09 -

Curved line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
30th Apr 2024REGISTERE-PRINCIPAL REGISTER
30th Apr 2024NOTICE O REGISTRATION CONIRMATION EMAILE
29th Mar 2024NOTICE O ACCEPTANCE O STATEMENT O USE E-MAILE
28th Mar 2024ALLOWE PRINCIPAL REGISTER - SOU ACCEPTE
06th Mar 2024STATEMENT O USE PROCESSING COMPLETE
06th Mar 2024CASE ASSIGNE TO INTENT TO USE PARALEGAL
14th Feb 2024TEAS STATEMENT O USE RECEIVE
14th Feb 2024USE AMENMENT ILE
29th Aug 2023NOA E-MAILE - SOU REQUIRE ROM APPLICANT
04th Jul 2023OICIAL GAZETTE PUBLICATION CONIRMATION E-MAILE